MAPT and tauopathy: Moreover, mice expressing antiaggregation mutations in tau do not exhibit tau-related neuropathology [26], and inhibition of tau aggregation alleviates tauopathy in the C. elegans model of tauopathy and P301S tau transgenic mice [27, 28].